Asensus Surgical Receives CE Mark for Expanded Machine Vision Capabilities
January 23, 2023 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update
January 09, 2023 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Surgical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Announces Kitakyushu General Hospital in Japan to Initiate Second Senhance System
January 03, 2023 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Announces Senhance Program Initiation at Kashiwa Kosei General Hospital of Japan
December 29, 2022 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Announces Senhance System Placement at GPR Klinikum Rüsselsheim of Germany
December 19, 2022 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Announces Additional Senhance Surgical System Sale
December 08, 2022 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Surgical to Participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
November 28, 2022 06:55 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial...
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2022
November 10, 2022 16:05 ET
|
Asensus Surgical, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
Asensus Surgical Announces Ludwig Maximilians University in Germany to Initiate Senhance Pediatric Surgery Program
November 08, 2022 06:55 ET
|
Asensus Surgical, Inc.
First Hospital to Initiate a Senhance System Dedicated to Pediatric Procedures9th Hospital in Germany to Utilize Senhance RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Asensus...